nameplate

Antibody Engineering - December 5-9, 2010 - Hilton San Diego Bayfront Hotel - San Diego, CA Antibody Therapeutics - December 7-9, 2010
banner area

Registration

Register Today!
Register by Friday, September 10 to Save $300. » View Pricing

Add to Outlook Diary

Find Another IBC Event

Event Search Form by Industry

CSS

Event Information

Antibody Engineering and Immunotherapeutics for the 21st Century

December 05 - 09, 2010 · Hilton San Diego Bayfront Hotel · San Diego, CA

Annual Meeting of The Antibody Society

Alternate Language Options: Japanese Korean Taiwanese Chinese

Document Title

Event Overview

Event Overview

The Strongest Faculty and Most Leading Edge Science of Any Protein Engineering Conference

We are looking forward to the 2010 meeting, in a new venue - Hilton San Diego Bayfront Hotel

Keynote Presentations:

Dennis R. Burton, Ph.D.

Protective Antibodies to Teach Vaccine Design
Dennis R. Burton, Ph.D., Professor, Department of Immunology and Microbial Science, The Scripps Research Institute

George P. Smith, Ph.D.

Twenty-Two Years of Success--and Failure
George P. Smith, Ph.D., Professor of Biological Sciences, University of Missouri

Richard A. Lerner, M.D.

Combinatorial Antibody Libraries from Patients with Acute Infection or Transplant Rejection Reveal the Good and Bad of Immunological Attack
Richard A. Lerner, M.D., President, The Scripps Research Institute

Sir Gregory Winter, FRS

Making Therapeutic Drugs by Phage Display: Combining Biology and Chemistry
Sir Gregory Winter, FRS, Head of Division of Protein & Nucleic Acid Chemistry, Laboratory of Molecular Biology, Medical Research Council, United Kingdom

The 2010 Meeting will Cover These Topics:

Antibody Engineering

  • Deep Sequencing
  • Neutralizing Antibodies and Identification of Vaccine Targets
  • 20 Years of Phage Display
  • Antibody Biosynthesis, Structure and Stability
  • Antibody Half-Life: the Long and the Short of It
  • Antibodies in a Complex Environment
  • Targeted Drug Loaded Nanoparticles
  • Antibody Targeted Cancer Therapeutics
  • Value and Limitations of Preclinical Models for Antibody Therapeutics

Antibody Therapeutics

  • Preclinical Development of Therapeutic Antibodies
  • Biosimilar and Biobetter Antibodies
  • Intellectual Property, Business and Regulatory Issues
  • Clinical Development of Therapeutic Antibodies

Plus Pre-Conference Workshop and Training Courses On:

  • Deep Sequencing of Antibody Genes: The Technology, Data Storage and Analysis
  • Introduction to Antibody Engineering
  • Protein Characterization for Biotechnology Product Development

» Conference Advisory Board: See who is helping to plan the conference topics

» See Why So Many Attendees Return Year After Year

footer

Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com